TRPC6 and ischemic stroke: In a rat model of ischemic stroke, NPD1 administration is associated with a significantly elevated TRPC6 and CREB activity, while the inhibition of the MEK/ERK pathway results in a decrease in NPD1 neuroprotective activity.